The report will be delivered in 2-3 business days.

Nucleic Acid Based Gene Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030

Starting Price : $5000 | Pages : 175 | Published : March 2021 | SKU CODE : 7614 | Format :


The nucleic acid-based gene therapy market consists of sales of nucleic acid-based gene therapy products and services. Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

The nucleic acid-based gene therapy market covered in this report is segmented by technology into anti-sence and anti-gene, short inhibitory sequences, gene transfer therapy, nucleoside analogs, ribozymes, aptamers, others. It is also segmented by application into oncology, muscular dystrophy/ muscular disorders, rare diseases and by end user into hospitals and clinics, academic and research institutes.

The global nucleic acid based gene therapy market is expected to grow from $0.56 billion in 2020 to $0.61 billion in 2021 at a compound annual growth rate (CAGR) of 8.9%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The nucleic acid-based gene therapy market is expected to reach $0.85 billion in 2025 at a CAGR of 9%.

Rising financial support by the government and the companies is projected to drive the demand for nucleic acid based gene therapy. Nucleic acid therapeutics are analogs of naturally occurring acids or proteins responsible for genetic expression. The traditional therapies do not have any cure for the treatment of diseases such as cystic fibrosis, hemophilia, sickle cell anaemia, thalassemia, and diabetes. Genetic profiling and molecular target identification form the backbone of these classes of drugs. Nucleic acid medication has greater potential for the treatment of these diseases, as they target the genetic basis of diseases and have a permanent cure. Rising financial support by the government and the companies dealing in the market for gene therapy is expected to contribute to increasing the demand for nucleic acid-based gene therapies. For instance in October 2019, the USA National Institutes of Health (NIH) announced plans to invest $100 million for the next four years to cure HIV and sickle cell disease with gene therapies. The government support for gene therapies will contribute to the growth of the market.

Stringent regulations imposed on gene therapies raises the price of gene therapies, which in turn hinders the demand for nucleic acid-based gene therapies. The excessive regulatory oversights create an expensive and elongated route for approval increasing the expenses. According to Foundation for Economic Education (FEE), unlike other drugs approved or regulated by the Food and Drug Administration (FDA), gene therapies are not only subject to the regulatory structure of FDA, but also the Recombinant DNA Advisory Committee and Office of Biotechnology Activities. Also, as estimated by FEE, an approved gene therapy drug cost nearly $5.0 billion, which is five times higher than that of the average cost of FDA approval. The high cost of gene therapeutics drugs places them beyond the financial reach of the populace. This scenario is anticipated to restrain the market growth of the nucleic acid-based gene therapy market.

In May 2018, Vectalys, a leading biotechnology company specializing in the manufacturing of high-quality solutions for gene delivery and FlashCell, a company engaged in developing non-integrated lentiviral delivered RNA Therapeutics announced the merger to create Flash Therapeutics, a privately held gene therapy company developing cell and gene therapeutics. The new company Flash Therapeutics is expected to focus on the development of RNA therapeutics based on LentiFlash, a non-integrative lentiviral delivery technology for incurable diseases.

Major players in the nucleic acid-based gene therapy market are Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene and Copernicus Therapeutics.

The regions covered in the nucleic acid-based gene therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nucleic acid-based gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global nucleic acid based gene therapy market is segmented -

1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Others

2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases

3) By End User: Hospitals And Clinics, Academic And Research Institutes

    1. Executive Summary

    2. Nucleic Acid Based Gene Therapy Market Characteristics

    3. Nucleic Acid Based Gene Therapy Market Trends And Strategies

    4. Impact Of COVID-19 On Nucleic Acid Based Gene Therapy

    5. Nucleic Acid Based Gene Therapy Market Size And Growth

    5.1. Global Nucleic Acid Based Gene Therapy Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Nucleic Acid Based Gene Therapy Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Nucleic Acid Based Gene Therapy Market Segmentation

    6.1. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Anti-Sence and Anti-Gene

    Short Inhibitory Sequences

    Gene Transfer Therapy

    Nucleoside Analogs

    Ribozymes

    Aptamers

    Others

    6.2. Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oncology

    Muscular Dystrophy/ Muscular Disorders

    Rare Diseases

    6.3. Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospitals And Clinics

    Academic And Research Institutes

    7. Nucleic Acid Based Gene Therapy Market Regional And Country Analysis

    7.1. Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Nucleic Acid Based Gene Therapy Market

    8.1. Asia-Pacific Nucleic Acid Based Gene Therapy Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Nucleic Acid Based Gene Therapy Market

    9.1. China Nucleic Acid Based Gene Therapy Market Overview

    9.2. China Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Nucleic Acid Based Gene Therapy Market

    10.1. India Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Nucleic Acid Based Gene Therapy Market

    11.1. Japan Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Nucleic Acid Based Gene Therapy Market

    12.1. Australia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Nucleic Acid Based Gene Therapy Market

    13.1. Indonesia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Nucleic Acid Based Gene Therapy Market

    14.1. South Korea Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Nucleic Acid Based Gene Therapy Market

    15.1. Western Europe Nucleic Acid Based Gene Therapy Market Overview

    15.2. Western Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Nucleic Acid Based Gene Therapy Market

    16.1. UK Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Nucleic Acid Based Gene Therapy Market

    17.1. Germany Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Nucleic Acid Based Gene Therapy Market

    18.3. France Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Nucleic Acid Based Gene Therapy Market

    19.1. Eastern Europe Nucleic Acid Based Gene Therapy Market Overview

    19.2. Eastern Europe Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Nucleic Acid Based Gene Therapy Market

    20.1. Russia Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Nucleic Acid Based Gene Therapy Market

    21.1. North America Nucleic Acid Based Gene Therapy Market Overview

    21.2. North America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Nucleic Acid Based Gene Therapy Market

    22.1. USA Nucleic Acid Based Gene Therapy Market Overview

    22.2. USA Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Nucleic Acid Based Gene Therapy Market

    23.1. South America Nucleic Acid Based Gene Therapy Market Overview

    23.2. South America Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Nucleic Acid Based Gene Therapy Market

    24.1. Brazil Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Nucleic Acid Based Gene Therapy Market

    25.1. Middle East Nucleic Acid Based Gene Therapy Market Overview

    25.2. Middle East Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Nucleic Acid Based Gene Therapy Market

    26.1. Africa Nucleic Acid Based Gene Therapy Market Overview

    26.2. Africa Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Nucleic Acid Based Gene Therapy Market Competitive Landscape And Company Profiles

    27.1. Nucleic Acid Based Gene Therapy Market Competitive Landscape

    27.2. Nucleic Acid Based Gene Therapy Market Company Profiles

    27.2.1. Celsion Corporation

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Wave Life Sciences

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Imugene

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Caperna

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Phylogica

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Nucleic Acid Based Gene Therapy Pipeline Analysis

    29. Key Mergers And Acquisitions In The Nucleic Acid Based Gene Therapy Market

    30. Nucleic Acid Based Gene Therapy Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Celsion Corporation Financial Performance
  • Table 28: Wave Life Sciences Financial Performance
  • Table 29: Imugene Financial Performance
  • Table 30: Caperna Financial Performance
  • Table 31: Phylogica Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Nucleic Acid Based Gene Therapy Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Nucleic Acid Based Gene Therapy Market, Segmentation By End User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Nucleic Acid Based Gene Therapy Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Nucleic Acid Based Gene Therapy Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: China, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: India, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Japan, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: Australia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: Indonesia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: South Korea, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Western Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: UK, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Germany, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: France, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Eastern Europe, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Russia, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: North America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: USA, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South America, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Brazil, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Middle East, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Africa, Nucleic Acid Based Gene Therapy Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Celsion Corporation Financial Performance
  • Figure 28: Wave Life Sciences Financial Performance
  • Figure 29: Imugene Financial Performance
  • Figure 30: Caperna Financial Performance
  • Figure 31: Phylogica Financial Performance
Global Clinical Oncology Next Generation Sequencing Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cervical Cancer Diagnostics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cerebrospinal Fluid Management (CSF) Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cell Culture Consumables And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global CAR-T Therapy Pipeline Analysis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Surgery Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Cardiovascular Medical Lasers Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Stem Cell Therapy Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Remdesivir Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
CRISPR Technology Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Gene Editing Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Microbiology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Implications And Growth To 2030
View Report
Synthetic Biology Global Market Report 2021: COVID-19 Growth And Change To 2030
View Report
Cell Therapy Global Market Report 2021: COVID 19 Growth And Change to 2030
View Report
Next Generation Sequencing Market - By Product Type (Kits And Consumables, Software, Instruments), By Technology (Ion Semiconductor Sequencing, Sequencing by Synthesis, Single-molecule Real-time Sequencing, Other Sequencing Technologies, Nanopore Sequencing), By Application (Drug Discovery, Diagnostics, Other Applications, Telepsychiatry), And By Region, Opportunities And Strategies – Global Next Generation Sequencing Market Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)